SKYRIZI
SKYRIZI
Approved
DIN Number
02532093
Drug Class
Human
Market Date
Mar 14, 2023
Company
HC
Abbvie Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02532093
AIG Number0161390002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L04AC18 RIZANKIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification84:06.28
Health Canada Classification
ACTIVE INGREDIENTS (1)
RISANKIZUMABActive
Strength: 360 MG / 2.4 ML
Monograph: RISANKIZUMAB